Promega Corporation

AKT1 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human AKT1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. AKT1/PKBα is a serine/threonine kinase that belongs to the AKT family. AKT1 is activated in cells in response to diverse stimuli such as hormones, growth factors and extracellular matrix components and is involved in glucose metabolism, transcription, survival, cell proliferation, angiogenesis and cell motility. AKT1 is frequently overexpressed and active in many types of human cancers including cancers of colon, breast, brain, pancreas and prostate as well as lymphomas an...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega KK only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

AKT1 Kinase Enzyme System

Close Window

AKT1 Kinase Enzyme System

 Components

10μg
- V1911 Please Enquire

AKT1 Kinase Enzyme System

Close Window

AKT1 Kinase Enzyme System

 Components

1mg
- V1912 Please Enquire

ADP-Glo™ Kinase Assay + AKT1 Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + AKT1 Kinase Enzyme System

 Components

  • AKT1 Kinase Enzyme System

    V19111 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9061 Please Enquire


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V1911, V1912, V9061 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9061 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9061 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9061 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9061 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9061 U.S. Pat. No. 8,183,007 and other patents pending.

V9061 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9061 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.